GLOBAL HUNTINGTON'S DISEASE THERAPEUTICS MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Jan 2019 120

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.

Scope of the Report:
This report focuses on the Huntington's Disease Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The demand for Huntington’s disease (HD) therapeutics as one of the primary growth factors for the Huntington’s disease therapeutics market. HD is equally prevalent in both males and females and affects people irrespective of their ethnicity. The disease symptoms may appear anytime in the individual’s life and the etiology is genetic. The person who inherits the mutated genes from their affected parents will probably suffer from the disease sometime in their lifetime.
The Americas is witnessing increasing incidences of HD. The availability of increased patient pool and the rise in government initiatives boost the research and development of novel therapeutics for the treatment of HD. The rising investments towards the launch of new drugs for the treatment of chorea will positively influence the growth of the Huntington’s disease therapeutics market in this region.
The worldwide market for Huntington's Disease Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
- F. Hoffmann-La Roche
- H. Lundbeck
- Prana Biotechnology
- Teva Pharmaceutical Industries
- Horizon Pharma

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Antidopaminergics
- Anticonvulsants
- Antipsychotics
- Antidepressants

Market Segment by Applications, can be divided into
- Hospitals
- Clinics
- Diagnostic Centers

There are 15 Chapters to deeply display the global Huntington's Disease Therapeutics market.
Chapter 1, to describe Huntington's Disease Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Huntington's Disease Therapeutics, with sales, revenue, and price of Huntington's Disease Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Huntington's Disease Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Huntington's Disease Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Huntington's Disease Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Jun 19)

Dioscorea Polystachya is a species of flowering plant in the yam family, which grows throughout East Asia yet native to C Sco...

(Jun 19)

Chinese Yam is a species of flowering plant in the yam family, which grows throughout East Asia yet native to China. Scope of...

(Jun 19)

Cicada Shell is the shell of insect Cryptotympana pustulata Fabricius, the family of Cicadidae. Scope of the Report: T...

(Jun 19)

Cicada Slough is the shell of insect Cryptotympana pustulata Fabricius, the family of Cicadidae. Scope of the Report: ...

(Jun 19)

Periostracum Cicadae is the skin that has been removed from Cicada, which has medicinal value. Scope of the Report: Th...

(Jun 19)

Ganoderma lucidum, commonly known as the lingzi mushroom, is frequently used in traditional Chinese medicine. Its popularity extends to Japa...

GLOBAL HUNTINGTON'S DISEASE THERAPEUTICS MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use JUNE15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy